APIMEDS PHARMACEUTICALS US, INC. Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net of $282.99 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. gain (loss) on derivative instruments held for trading purposes, net for the quarter ending 2026-06-30 was $282.99K.
- APIMEDS PHARMACEUTICALS US, INC. gain (loss) on derivative instruments held for trading purposes, net for the quarter ending 2026-03-31 was $2.03K.
- APIMEDS PHARMACEUTICALS US, INC. gain (loss) on derivative instruments held for trading purposes, net for fiscal 2025 was $97.00.
| Period end | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 3 month | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 6 month | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 12 month |
|---|---|---|---|
| 2026-06-30 | $282.99K 10-Q · filed 2026-08-14 | $285.02K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.03K 10-Q · filed 2026-05-26 | ||
| 2025-12-31 | $97.00 10-K · filed 2026-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |